Flow cytometric analysis revealed an increase in the mean fluorescence intensity of CXCL16 in Ph+ B-ALL cells after IL-17A treatment, suggesting that IL-17A increases CXCL16 expression in Ph+ B-ALL cells on a per-cell basis (Fig. 6d). The gene discussed is CXCL16; the disease is acute lymphoblastic leukemia.